New Diamyd Medical listed on NASDAQ OMX First North on May 20, 2013
Diabetes has developed into a major global problem. The disorder is affecting younger and younger people and complications related to diabetes are currently among the most common causes of death in many countries. In conjunction with the spin-out of the new Diamyd Medical from the Parent Company in April 2013, a dedicated diabetes company was formed. The company will now be listed on NASDAQ OMX First North and the first day of trading is May 20. The company description ahead of the listing will be available in Swedish on the company’s website www.diamyd.com. The company intends to implement a